Emily Davis, DO

bOARD CERTIFIED DERMATOLOGIST

board certified mohs surgeon

Surgical Fellowship
Trinity Health, Michigan State University

Dermatology Residency
Trinity Health, Michigan State University

Internship
Brookwood Baptist Health System

Medical School
Alabama College of Osteopathic Medicine
Summa Cum Laude

Undergraduate Education
University of Alabama, Bachelor of Science in Biology
Summa Cum Laude

Professional Affiliations
American Board of Dermatology, Diplomate
American Academy of Dermatology, Fellow
American College of Mohs Surgery, Member
American Medical Association, Member
American Society for Dermatologic Surgery, Member
Women’s Dermatologic Society, Member
Phi Beta Kappa, Member
Gold Humanism Honor Society, Member

Dr. Davis is an Alabama native who is thrilled to be a Georgia transplant. She attended American Christian Academy for high school, where she excelled academically and athletically by competing in all-star & high school cheerleading and tennis. She graduated from the University of Alabama, Honors College Program with a Bachelor of Sciences in Biology. Dr. Davis attended medical school at the Alabama College of Osteopathic Medicine in Dothan, AL, and completed her 3rd and 4th year clinical rotations in Mobile, AL at South Alabama College of Medicine facilities. She graduated top in her class with a 4.00 in medical school.

After medical school, Dr. Davis completed her Transitional Year Internship with Brookwood Baptist Health Systems, where she received an excellent foundation of training in internal medicine. She then completed her three-year ACGME-accredited Dermatology residency at Trinity Health Livingston & Ann Arbor Hospital, where she received rigorous training and exposure to complex medical dermatology, general & pediatric dermatology, inpatient dermatology, cosmetic dermatology, surgical dermatology, and skin of color. After residency, Dr. Davis stayed in Michigan to complete a dual-accredited ACGME and ACMS Mohs Micrographic Surgery and Dermatologic Oncology Fellowship, where she completed over 1,000 surgical and reconstructive cases as the primary surgeon. 

In her free time, Dr. Davis enjoys participating in exercise classes, playing tennis, water & snow skiing, traveling, Crimson Tide football, and spending time with her husband, John, family, friends, and her two miniature dachshunds, Winston and Oscar.

Dr. Davis enjoys meeting people of all backgrounds and walks of life. As a perfectionist herself, Dr. Davis’s aims are to practice evidence-based medicine and to cure skin cancer while providing the least amount of scarring possible. She listens to the needs of her patients and is sensitive to their cosmetic concerns and desires. She is excited to serve the communities of southeast Georgia.

Serving these locations:

Selected Publications
Visconti MJ, Davis ER, Krach KJ. Surgical Scar Revision: Boards Fodder. DermWorld, AAD Directions in Residency. Oct 2022. Winter (January) 2023 Issue: p. 4-5.

Visconti MJ, Davis ER, Healey B, Krach KJ. Mohs Micrographic Surgery: Boards Fodder. DermWorld, AAD Directions in Residency. Fall (November) 2022 p.1-3.

Visconti MJ, Davis ER, Krach KJ. Non-Surgical Scar Revision: Boards Fodder. DermWorld, AAD Directions in Residency. Oct 2022. Winter (January) 2023 Issue: p. 4-5.

Visconti MJ, Davis ER. Dermabrasion: Boards Fodder. NextSteps in Dermatology. October 2022.

Healey B, Davis ER, Heath C, Sabzevari N, Stewart D. The utility of scribes in the academic dermatology clinic: An opportunity for mutual benefit to patients, trainees, and shareholders. Clin Dermatol. 2022;S0738-081X(22)00016-5. 

Buckland M, Davis ER, Krach K. Importance of Preoperative Evaluation for Mohs Surgery. Dermatol Surg. 2021;47(7):994-995.

Zambrano R, Moesch J, Davis ER, Heaphy MR Jr, Miller R. Superficial Clear Cell Sarcoma (Melanoma of Soft Parts) of the Large toe in an 80-Year-Old Female With a Rare Cytogenetic Translocation. Cureus. 2020;12(11):e11719. Published 2020 Nov 26. 

Patel NU, Davis ER (Shealy), Vera NC, Wetzel M, Feldman SR. A Review of the Use of Secukinumab for Psoriatic Arthritis. Rheumatol Ther. 2017;4(2):233-246.

Baroudi B, Davis ER (Shealy), Cardwell L, Feldman S. Olumacostat glasaretil. Acetyl-CoA carboxylase (ACC) inhibitor. Drugs of the Future. 2018;43(3):175.